Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 28 Aug 2026 for Cue Biopharma, Inc.. Read the official filing
Filing timeline
BuySalePasha Sarraf
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-53.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Pasha Sarraf: trading record in brief
Pasha Sarraf appears in our data through filings on Cue Biopharma, Inc. shares, published by SEC (Form 4). The record holds 3 filings, for trades running from 30 December 2025 to 9 July 2026.
Purchases make up the whole of the open-market record (1 purchase, €1,111). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 share grants. Since January 2026: 1 purchase and no sales on the market.
On 28 August 2026 came the latest disclosure, a share grant in Cue Biopharma, Inc. The latest purchase dates back some time: it was published 289 days ago, on 2 January 2026. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Pasha Sarraf
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
18,400 shares0Common StockSEC:0002059447-26-000006:0
21,800 shares0Common StockSEC:0002059447-26-000004:0
4,229 shares@ US$0.3094100.0% of flowCommon StockSEC:0001193125-26-000900:0
Canonical exit: 30 Mar 2026 (T+90)
3 of 3 declarations
